1 Min Read
June 22 (Reuters) - Glenmark Pharmaceuticals Ltd
* Receives tentative ANDA approval for Solifenacin Succinate tablets, 5 mg and 10 mg Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.